Clinical Research Directory
Browse clinical research sites, groups, and studies.
Zephyr Valve Registry (ZEVR)
Sponsor: Pulmonx Corporation
Summary
The purpose of this Post-Approval Registry is to gather ongoing safety and effectiveness assessment of the Zephyr Valve treatment in a real-world setting.
Official title: Zephyr Valve Registry
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2019-11-25
Completion Date
2026-12-31
Last Updated
2025-04-29
Healthy Volunteers
No
Conditions
Interventions
Zephyr Valve Procedure
The Pulmonx Zephyr Endobronchial Valve is an implantable bronchial valve intended to decrease volume in targeted regions of the lung. It is indicated for the treatment of patients with severe emphysema. The Zephyr Valves are placed in the diseased region of the lung using bronchoscopy. As the diseased region of the lung shrinks in size, healthier regions may expand and function more efficiently, resulting in improved breathing.
Locations (11)
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of Chicago
Chicago, Illinois, United States
Northwestern Medicine
Winfield, Illinois, United States
Henry Ford Hospital
Detroit, Michigan, United States
The Lung Center
DuBois, Pennsylvania, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Temple University Hospital
Philadelphia, Pennsylvania, United States
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States
Houston Methodist
Houston, Texas, United States
Inova Health
Fairfax, Virginia, United States
Froedtert Memorial-Medical College of Wisconsin
Milwaukee, Wisconsin, United States